RJA
ASXC

Raymond James & Associates’s Asensus Surgical, Inc. ASXC Stock Holding History

Raymond James & Associates’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-31,234
Closed -$58K – 4301
2021
Q3 		$58K Sell
31,234
-15,697
-33% -$35.2K ﹤0.01% 3902
2021
Q2 		$149K Sell
46,931
-68,569
-59% -$171K ﹤0.01% 3754
2021
Q1 		$375K Buy
115,500
+45,145
+64% +$164K ﹤0.01% 3217
2020
Q4 		$44K Hold
70,355
– – ﹤0.01% 3635
2020
Q3 		$24K Buy
+70,355
New +$27.2K ﹤0.01% 3501
2019
Q4 		– Sell
-11,107
Closed -$89K – 3766
2019
Q3 		$89K Sell
11,107
-1,556
-12% -$21.2K ﹤0.01% 3401
2019
Q2 		$224K Sell
12,663
-102
-0.8% -$2.23K ﹤0.01% 3182
2019
Q1 		$395K Buy
12,765
+3,733
+41% +$125K ﹤0.01% 2820
2018
Q4 		$265K Buy
9,032
+3,712
+70% +$169K ﹤0.01% 2946
2018
Q3 		$401K Sell
5,320
-331
-6% -$22.4K ﹤0.01% 2856
2018
Q2 		$320K Sell
5,651
-39
-0.7% -$1.42K ﹤0.01% 2979
2018
Q1 		$126K Buy
5,690
+639
+13% +$14.6K ﹤0.01% 3237
2017
Q4 		$127K Sell
5,051
-62
-1% -$1.91K ﹤0.01% 3173
2017
Q3 		$95K Buy
5,113
+2,316
+83% +$26.9K ﹤0.01% 3187
2017
Q2 		$26K Buy
2,797
+1,065
+61% +$10.1K ﹤0.01% 3238
2017
Q1 		$27K Buy
1,732
+446
+35% +$7.73K ﹤0.01% 3192
2016
Q4 		$22K Buy
1,286
+355
+38% +$7.28K ﹤0.01% 3144
2016
Q3 		$20K Sell
931
-376
-29% -$6.87K ﹤0.01% 3139
2016
Q2 		$21K Buy
1,307
+458
+54% +$14.4K ﹤0.01% 2934
2016
Q1 		$47K Buy
+849
New +$36.4K ﹤0.01% 2791

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Raymond James & Associates's ASXC Position: Q4 2021 in Review

Raymond James & Associates sold out of Asensus Surgical, Inc. (ASXC) in Q4 2021, closing a stake of 31,234 shares — an estimated $58K sold.

Raymond James & Associates first reported a position in ASXC in Q1 2016 and held it in 20 quarters. The position peaked at $401K in Q3 2018. 114 funds tracked by Wall St. Rank hold ASXC as of Q4 2021.

  • Raymond James & Associates reported no remaining Asensus Surgical, Inc. position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 31,234 Asensus Surgical, Inc. shares in Q4 2021, an estimated $58K.
  • Raymond James & Associates first reported a position in Asensus Surgical, Inc. in Q1 2016 and held it in 20 quarters.
  • Raymond James & Associates's Asensus Surgical, Inc. position peaked at $401K in Q3 2018.
  • 114 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.